tiprankstipranks
Oncolytics Biotech (TSE:ONC)
TSX:ONC

Oncolytics Biotech (ONC) Technical Analysis

170 Followers

Summary of all the Indicators

Overall Consensus
Neutral
7Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Oncolytics Biotech’s (ONC) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Oncolytics Biotech is a Sell.
Oncolytics Biotech’s (ONC) 20-Day exponential moving average is 1.41, while Oncolytics Biotech’s (ONC) share price is C$1.4, making it a Sell.
Oncolytics Biotech’s (ONC) 50-Day exponential moving average is 1.44, while Oncolytics Biotech’s (ONC) share price is C$1.4, making it a Sell.

Oncolytics Biotech (ONC) Pivot Points

Jul 08, 2024, 05:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.34
1.36
1.39
1.41
1.44
1.46
1.49
Fibonacci
1.36
1.38
1.39
1.41
1.43
1.44
1.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oncolytics Biotech (ONC) Moving Averages

Jul 08, 2024, 05:24 PM
Period
Simple
Exponential
MA5
1.39Buy
1.40Buy
MA10
1.39Buy
1.39Buy
MA20
1.40Buy
1.41Sell
MA50
1.48Sell
1.44Sell
MA100
1.46Sell
1.54Sell
MA200
1.75Sell
1.91Sell
Oncolytics Biotech’s (ONC) 10-Day exponential moving average is 1.39, while Oncolytics Biotech’s (ONC) share price is C$1.4, making it a Buy.
Oncolytics Biotech’s (ONC) 100-Day exponential moving average is 1.54, while Oncolytics Biotech’s (ONC) share price is C$1.4, making it a Sell.
Oncolytics Biotech’s (ONC) stock price is C$1.4 and Oncolytics Biotech’s (ONC) 50-day simple moving average is 1.48, creating a Sell signal.
Oncolytics Biotech’s (ONC) stock price is C$1.4 and Oncolytics Biotech’s (ONC) 100-day simple moving average is 1.46, creating a Sell signal.
Oncolytics Biotech’s (ONC) stock price is C$1.4 and Oncolytics Biotech’s (ONC) 200-day simple moving average is 1.75, creating a Sell signal.

Oncolytics Biotech (ONC) Technical Indicators

Jul 08, 2024, 05:24 PM
Name
Value
Implied Action
RSI (14)
47.16
Neutral
STOCH (9,6)
77.78
Neutral
STOCHRSI (14)
75.19
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
11.41
Buy
Williams %R
-33.33
Buy
CCI (14)
5.03
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
49.66
Neutral
ROC
0.00
-
Oncolytics Biotech’s (ONC) Relative Strength Index (RSI) is 47.16, creating a Neutral signal.
Oncolytics Biotech’s (ONC) Trend Strength Indicator (ADX) is 11.41, creating a Buy signal.
Oncolytics Biotech’s (ONC) Commodity Channel Index (CCI) is 5.03, creating a Neutral signal.

FAQ

Is ONC a Buy, Hold, or Sell?
Based on ONC’s technical indicators, ONC is a Hold.
    What is ONC’s RSI (14)?
    ONC’s RSI (14) is 47.16, which suggests ONC is a Neutral.
      What is ONC’s MACD?
      ONC’s MACD is -0.02, which suggests ONC is a Sell.
        What is ONC’s 5-day moving average?
        ONC’s 5-day moving average is 1.39, which suggests ONC is a Buy.
          What is ONC’s 20-day moving average?
          ONC 20-day moving average is 1.40, which suggests ONC is a Buy.
            What is ONC’s 50-day moving average?
            ONC’s 50-day moving average is 1.48, which suggests ONC is a Sell.
              What is ONC’s 200-day moving average?
              ONC’s 200-day moving average is 1.75, which suggests ONC is a Sell.
                What is ONC’s Williams % R (14)?
                ONC’s Williams % R (14) is -33.33, which suggests ONC is a Buy.
                  What is ONC’s CCI (14)?
                  ONC’s CCI (14) is 5.03, which suggests ONC is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis